A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome
Clinical trial NCT03703908 · TERMINATED
Trial details
- NCT number
- NCT03703908
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2020-06-24
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.